B-Cell Receptor-Associated Protein 29 (BCAP29) (Middle Region) Peptide
BCAP29
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN973764
Quick Overview for B-Cell Receptor-Associated Protein 29 (BCAP29) (Middle Region) Peptide (ABIN973764)
Target
BCAP29
(B-Cell Receptor-Associated Protein 29 (BCAP29))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-BCAP29 antibody (Catalog #: ARP44557_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- BCAP29 (B-Cell Receptor-Associated Protein 29 (BCAP29))
-
Background
-
BCAP29 may play a role in anterograde transport of membrane proteins from the endoplasmic reticulum to the Golgi. BCAP29 may be involved in CASP8-mediated apoptosis.
Alias Symbols: BAP29, DKFZp686M2086
Protein Interaction Partner: BCAP31,PDXDC1,BCAP31
Protein Size: 337 -
Molecular Weight
- 39 kDa
-
Gene ID
- 55973
-
NCBI Accession
- NM_001008406, NP_001008406
-
UniProt
- A6NCU1
Target
-
You are here:
